These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1424362)

  • 41. Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with (99m)Tc-MIBI, (201)Tl, MRI and US.
    Wakamatsu H; Noguchi S; Yamashita H; Yamashita H; Tamura S; Jinnouchi S; Nagamachi S; Futami S
    Eur J Nucl Med; 2001 Dec; 28(12):1817-27. PubMed ID: 11734921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experimental studies of the physiologic properties of technetium-99m agents: myocardial transport of perfusion imaging agents.
    Meerdink DJ; Leppo JA
    Am J Cardiol; 1990 Oct; 66(13):9E-15E. PubMed ID: 2145753
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased accumulation of hexakis (2-methoxyisobutylisonitrile)technetium(I) in osteosarcoma and its metastatic lymph nodes.
    Caner B; Kitapçi M; Aras T; Erbengi G; Uğur O; Bekdik C
    J Nucl Med; 1991 Oct; 32(10):1977-8. PubMed ID: 1919741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Technetium-99m-sestamibi: another window on myocardial viability?
    Liu P
    J Nucl Med; 1991 Feb; 32(2):298-9. PubMed ID: 1825112
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparison of neutral and cationic myocardial perfusion agents: characteristics of accumulation in cultured cells.
    Kronauge JF; Chiu ML; Cone JS; Davison A; Holman BL; Jones AG; Piwnica-Worms D
    Int J Rad Appl Instrum B; 1992 Feb; 19(2):141-8. PubMed ID: 1601667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Technetium-99m-MIBI uptake in benign and malignant bone lesions: a comparative study with technetium-99m-MDP.
    Caner B; Kitapçl M; Unlü M; Erbengi G; Calikoğlu T; Göğüş T; Bekdik C
    J Nucl Med; 1992 Mar; 33(3):319-24. PubMed ID: 1531501
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decreased Tc-99m sestamibi uptake in a sternal brown tumor indicating response to anti metabolic therapy for secondary hyperparathyroidism.
    Ozkan E; Arslan N; Arslanoglu A; Karacalioglu AO
    Clin Nucl Med; 2007 Aug; 32(8):661-2. PubMed ID: 17667448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduction of 99mTc-sestamibi and 99mTc-tetrofosmin uptake in MRP-expressing breast cancer cells under hypoxic conditions is independent of MRP function.
    Kinuya S; Li XF; Yokoyama K; Mori H; Shiba K; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1529-31. PubMed ID: 14579093
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discordant uptake of MIBI and HMPAO.
    Lass P
    J Nucl Med; 1997 May; 38(5):828. PubMed ID: 9170457
    [No Abstract]   [Full Text] [Related]  

  • 50. Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability?
    Beanlands RS; Dawood F; Wen WH; McLaughlin PR; Butany J; D'Amati G; Liu PP
    Circulation; 1990 Nov; 82(5):1802-14. PubMed ID: 2225377
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Planar imaging techniques used with technetium-99m sestamibi to evaluate chronic myocardial ischemia.
    Maisey MN; Mistry R; Sowton E
    Am J Cardiol; 1990 Oct; 66(13):47E-54E. PubMed ID: 2145746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection and location of myocardial infarction using technetium-99m sestamibi imaging at rest.
    Boucher CA
    Am J Cardiol; 1990 Oct; 66(13):32E-35E. PubMed ID: 2145743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transient prolonged postischemic ventricular dilatation documented by 99mTc MIBI scan.
    Galli M; Giubbini R; Tavazzi L
    Chest; 1991 Jun; 99(6):1536-8. PubMed ID: 1828021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effects of ouabain on 201Tl and 99mTc MIBI kinetics in rat myocardium--in vivo study using miniature CsI detector].
    Tange S
    Kaku Igaku; 1992 Aug; 29(8):963-70. PubMed ID: 1331578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myocardial kinetics of Tc-MIBI in canine myocardium after dipyridamole.
    Glover DK; Okada RD
    Circulation; 1990 Feb; 81(2):628-37. PubMed ID: 2297867
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Noncardiac applications of hexakis(alkylisonitrile) technetium-99m complexes.
    Piwnica-Worms D; Holman BL
    J Nucl Med; 1990 Jul; 31(7):1166-7. PubMed ID: 2362196
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of technetium-99m-MIBI and technetium-99m-tetrofosmin uptake by musculoskeletal sarcomas.
    Söderlund V; Jonsson C; Bauer HC; Brosjö O; Jacobsson H
    J Nucl Med; 1997 May; 38(5):682-6. PubMed ID: 9170427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thallium-201 and technetium-99m-sestamibi for assessing viable myocardium.
    Bonow RO; Dilsizian V
    J Nucl Med; 1992 May; 33(5):815-8. PubMed ID: 1533248
    [No Abstract]   [Full Text] [Related]  

  • 59. A comparison of Tl-201, Tc-99m sestamibi, and Tc-99m tetrofosmin myocardial perfusion scintigraphy in patients with mild to moderate coronary stenosis.
    Reyes E; Loong CY; Harbinson M; Rahman S; Prvulovich E; Ell PJ; Anagnostopoulos C; Underwood SR
    J Nucl Cardiol; 2006 Jul; 13(4):488-94. PubMed ID: 16919572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Animal models in radiotracer design of a Tc-labelled myocardial perfusion imaging agent.
    Mousa SA
    Am J Physiol Imaging; 1991; 6(1):16-25. PubMed ID: 1828162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.